Pharmaceutical Drug Injury
Drugs with deadly or dangerous side effects often make it to the market because their potential dangers were not anticipated during clinical trials. These drugs are classified as defective and have been identified by the FDA as having dangerous side effects that may outweigh whatever benefits they provide. Such an FDA classification often leads to drug recalls, personal injuries, and lawsuits against drug companies.
Even if you feel you are not ready to file a suit, consult one of our qualified lawyers as soon as possible so that you will know your options. We do not charge any fees up front. In fact, we will only charge attorney’s fees if we obtain a financial settlement for you. If you don’t win, we won’t get paid a legal fee.
Call us at 1.800.241.9779 today for your free case evaluation.
Defective Drug Compensation
Current List Of Pharmaceutical Drug Injury Claims
Invokana, also known under the generic name canagliflozin, is a relatively new medication used to treat Type II diabetes. A large number of people using this medication have had diabetic ketoacidosis (DKA) requiring hospitalization, as well as amputation. The FDA has already required the drug’s makers to strengthen warnings about the risks of amputation as well as bone fractures. We are looking at these serious injury cases for potential litigation.
Taxotere, known generically as docetaxel, is a popular chemotherapy medication used to treat breast cancer, as well as other types of cancer. Among other potentially harmful side effects, Taxotere sometimes causes irreversible hair loss in patients who take it as part of a chemotherapy regimen. Taxotere has also been shown to cause a serious eye condition called canalicular stenosis, which results in watery eyes, among other side effects. If you took or are taking Taxotere as part of your cancer treatment and suffered hair loss, watery eyes, or other major health problems, you may qualify for compensation.
Zofran (ondansetron) is used to help combat nausea during pregnancy. We are investigating cases where women were using this drug in the first trimester of pregnancy and gave birth to an infant with serious birth defects—primarily heart defects and skeletal defects. Use of Zofran has been linked with infant musculoskeletal anomalies as well as heart murmurs and septal defects in the hearts of newborns.
Zantac, the brand name of the medication ranitidine, is a popular prescription and over-the-counter medication used to treat reflux disease and heartburn. It blocks the overproduction of acid in the stomach. It has recently been taken off the market as it has been found to contain an impurity called N-Nitrosodimethylamine, or NDMA, which is linked to certain types of cancer, including those of the liver, stomach, esophagus, colon, and kidneys. If you have been prescribed Zantac or ranitidine and are still taking it, consult with your doctor immediately about these risks, and discuss potential compensation with an experienced prescription drug attorney.
Recently, scientific studies have linked Elmiron, a medication for interstitial cystitis, to retinal damage. Specifically, taking high doses of Elmiron, known commonly as pentosan polysulfate sodium, have an increased incidence of maculopathy over years of use. Maculopathy is a permanent change in a patient’s retinas, resulting in irreversible vision loss.
If you have been diagnosed with a serious change in your vision after using Elmiron for an extended period of time, contact us to see if we can help you.
This medication, marketed under the brand name Diovan, is often prescribed for treating congestive heart failure as well as high blood pressure. Valsartan has also been found to contain N-Nitrosodimethylamine, or NDMA, which is known to cause certain types of cancer as well as damage to the liver.
If the drug was used after January 2015 and the user was diagnosed with one of these types of cancer, we would like to investigate.
Frequently Asked Questions
A: Not always. Class-action is a type of lawsuit that allows a large number of people to join together to sue a company, usually under one representative or group of plaintiffs. If the parties reach a settlement, the class members share the compensation awarded to the plaintiffs. Sometimes rather than filing a class action, lawyers will pursue individual claims, or may opt for what is known as multi-district litigation, or MDL. MDL cases are heard in a single court, but remain separate cases.
A: Most likely, they will not. Doctors, like patients, are victims of the misinformation that big drug companies engage in when they fail to warn about the dangers of their products. The targets of medical liability lawsuits are the big pharmaceutical companies that manufacture and market these faulty medications.
A: It can sometimes take years for a pharmaceutical negligence case to be resolved, but sometimes the drug company will create a settlement program to compensate victims in order to end the lawsuit sooner.